Abstract
Differentiating patients with type 1 and type 2 myocardial infarction (MI) and acute
non-ischemic myocardial injury continues to be a problem for many clinicians. Type
1 MI is the most easily defined. It involves the rise and fall of blood troponin measurements
(only falling values if the patient arrives late) with an appropriate clinical observation
consistent with myocardial ischemia. Diagnosis and therapy of type 1 MI are well understood
and usually present no problem to the physician. The clinical scenarios leading to
type 2 MI and non-ischemic myocardial injury are, however, often fraught with greater
degrees of uncertainty. In addition, therapy for these latter 2 entities is poorly
defined. This review will present 3 patient scenarios that should help clinicians
understand the difference between these 3 entities as well as possible therapeutic
interventions.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction.Circulation. 2007; 116 (Eur Heart J. 2007; 28:2525-2538. J Am Coll Cardiol. 2007; 50: 2173-2195): 2634-2653
- Third universal definition of myocardial infarction.Eur Heart J. 2012; 33: 2551-2567
- Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction.Circulation. 2018; 138: e618-e651https://doi.org/10.1161/CIR.0000000000000617
- ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation. 2014; 130: e344-e426https://doi.org/10.1161/CIR.0000000000000134
- Cardiac troponin and defining myocardial infarction.Cardiovasc Res. 2021; 117: 2203-2215.
- Type 2 myocardial infarction: JACC review topic of the week.J Am Coll Cardiol. 2019; 73: 1846-1860
- Type 2 MI and myocardial injury in the era of high-sensitivity troponin.Eur Cardiol. 2022 Feb 17; 17: e03https://doi.org/10.15420/ecr.2021.42
- COVID-19 and cardiovascular disease: from bench to bedside.Circ Res. 2021; : 1214-1236
- Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week.J Am Coll Cardiol. 2020; 76: 1244-1258
- The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications.Circ Res. 2020; 127: 571-587
- Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?.Eur J Intern Med. 2022; 96: 13-16
- Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury.Circulation. 2019; 140: 1661-1678
Article Info
Publication History
Published online: March 24, 2022
Footnotes
Funding: None.
Conflict of Interest: None.
Authorship: All authors had access to the data and a role in writing this manuscript.
Identification
Copyright
© 2022 Published by Elsevier Inc.
